EpiCept’s Ceplene Product Receives Marketing Auth. by European Commission
Ceplene is administered for maintenance of first remission in patients with AML, the most common type of Leukemia in adults.
View ArticleJeff Margolis Examines How Western Companies Can Capitalize on the...
India is emerging as a significant player in the life science sector. The 2005 patent amendments have brought India into the modern world in terms of intellectual property.
View ArticleExecutives From Top Investment Firms Attended OneMedForum Kick Off Reception
OneMedPlace held a 2nd reception to promote OneMedForum New York 2012 last Thursday at The Chasson Group offices.
View ArticleInVivo Therapeutics Protects And Regenerates The Spinal Cord Resulting in...
Frank Reynolds, of InVivo Therapeutics (NVIV), says the company is on the verge of unprecedented technology for the treatment of the spinal cord.
View ArticleHashtag Biotech: Where to Find Investors on Twitter
"Hashtag Biotech" is a new weekly column in which OneMedPlace explores the power of Twitter and other social media tools in facilitating emerging growth company development. This week, we identify the...
View ArticleAdvaMed 2012: The MedTech Sector Event of the Year
The 6th Annual AdvaMed 2012 MedTech Conference kicks off October 1st for a 3-day event covering the hottest issues in the sector. This year, AdvaMed expects more than 2,100 attendees, 800 MedTech...
View ArticleOneMedRadio: AdvaMed 2012 — What to Watch For
OneMedRadio spoke with Ray Briscuso, Managing Partner and Producer of AdvaMed 2012, to learn about the can't miss highlights in conference programming. Briscuso also discussed the history of the...
View ArticlePress Release: Crystal Research Associates to Sponsor 6th Annual OneMedForum
Crystal Research Associates, LLC, an independent equity research firm, announced today a partnership with OneMedPlace to broaden services and provide additional visibility to research clients via the...
View ArticleDiagnostics: Biomarkers, Gene Patents, and Personalized Medicine in Jeopardy
Fallout from the the US Supreme Court landmark decision to deny two patents to Prometheus Laboratories may complicate the future profitability of the industry. If this is indeed a precedent-setting...
View ArticleOneMedPlace Announces Program Updates for Its 6th Annual “OneMedForum,” Jan....
The 6th Annual OneMedForum will take place concurrently with the JP Morgan Healthcare Conference and will feature over 1,000 attendees and more than 100 emerging growth companies from the biotech and...
View Article`OneMedForum` Panel to Address the Major Opportunities in Digital Health at...
OneMedPlace announced today that Peter Neupert of Health Evolution Partners and Jack Young of Qualcomm Ventures will participate in programming for the 6th Annual OneMedForum, January 7-9, 2013, in San...
View ArticleRidge Diagnostics, Inc. to Present on Blood Tests for Depression at OneMedForum
San Diego, CA January 8, 2013 – Ridge Diagnostics, Inc., a neurodiagnostic company, announced that Lonna J. Williams, CEO, will speak at the 6th Annual OneMedForum San Francisco 2013, to be held at The...
View ArticleOneMedRadio: Vijay Aggarwal Discusses Diagnostics Trends in 2013 (Part I)
As we approach mid-year, many questions raised in the past year surrounding the state of healthcare company growth development have yet to be answered. The diagnostics industry, one of the fastest...
View ArticleThe 10 “Do’s and Don’t's” When Networking at a Healthcare Conference
With OneMedForumNY 2013 just one month away (and a few healthcare conferences coming up), we thought it best to step away from our usual editorial functions and instead offer a 'how to' on enhancing...
View ArticleOneMedPlace announces program for the Seventh Annual OneMedForum: Investing...
OneMedPlace announces program for the Seventh Annual OneMedForum: Investing in Healthcare 2014, Jan. 13-15
View Article